Market Research Reports

All Reports Home

Categories

Countries

Pharmaceuticals Reports

Medical Radiation Detection Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Gas-filled Detector, Scintillators), By Product (Personal Dosimeters, Area Process Dosimeters), By End-use (Hospitals, Ambulatory Surgical Centers, Diagnostic Imaging Centers, Homecare), By Region & Competition, 2020-2030F

Increasing prevalence of cancer is expected to drive the Global Medical Radiation Detection Market growth in the forecast period, 2026-2030F.Read More

India Vitamin B1 Market By Product Type (Thiamine Nitrate Type, Thiamine Hydrochloride Type, Others), By Source (In-house v/s Contract Manufacturing Organizations), By Form (Tablet, Capsule, Injectable Solution), By Dosage Strength (50mg, 100mg, 250mg), By Distribution Channel (Online v/s Offline), By Application (Beriberi, Wernicke's Encephalopathy Syndrome, Delirium, Others), By End User (Adult v/s Pediatric), By Company, Region, Forecast & Opportunities, 2020-2030

Growing awareness pertaining to health among the population is expected to drive the growth of India vitamin B1 market in the forecast period, 2026-2030Read More

Adalimumab Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Biologics, Biosimilars), By Therapeutic Area (Rheumatoid Arthritis, Psoriatic Arthritis, Psoriasis, Crohn’s Disease, Others), By Region and Competition, 2020-2030F

Growth in healthcare industry and surge in technological advancements are factors driving the Global Adalimumab Market in the forecast period 2026-2030. Read More

Antimalarial Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Drug Type (Quinine, Chloroquine, Proguanil, Amodiaquine, Mefloquine, Hydroxychloroquine, Pyrimethamine, Others), By Malaria Type (Plasmodium Falciparum, Plasmodium Malariae, Plasmodium Vivax, Plasmodium Ovale, Plasmodium Knowlesi), By Region and Competition, 2020-2030F

Growth in healthcare industry and surge in technological advancements are factors driving the Global Antimalarial Drugs Market in the forecast period 2026-2030. Read More

Spain Retail Pharmacy Market, By Product (Prescription Drugs, Over-the-Counter (OTC) Products, Health and Wellness Products, Medical Devices and Equipment, Personal Care Products), By Distribution Channel (Chain Pharmacy, Independent Pharmacy, Other), By Region, Competition, Forecast & Opportunities, 2020-2030F

Aging Population and Rising Chronic Disease Burden and Digitalization and Omnichannel Retailing are factors driving the Spain Retail Pharmacy market in the Read More

United States Small Molecule Innovator API CDMO Market By Stage Type (Preclinical, Clinical, Commercial), By Service (Process Development, Contract Manufacturing, Analytical Testing and Quality Control, Packaging and Supply Chain Solutions, Others), By Customer Type (Pharmaceutical, Biotechnology), By Therapeutic Area (Cardiovascular Diseases, Oncology, Respiratory Disorders, Neurology, Metabolic Disorders, Infectious Diseases, Others), By Region and Competition, Forecast & Opportunities, 2020-2030F

Rising demand for targeted therapies and increasing R&D investments by pharmaceutical companies are the factors driving the United States Small Molecule Read More

India Pneumococcal Vaccine Market By Vaccine Type (Pneumococcal Conjugate Vaccine, Pneumococcal Polysaccharide Vaccine), By End Use (Public Sector, Private Sector), By Region, Competition, Forecast & Opportunities, 2020-2030F

Rising geriatric population and expanding healthcare infrastructure are factors driving the India Pneumococcal Vaccine Market in the forecast period 2026-2030. Read More

United States Clinical Trial Investigative Site Network Market By Phase (Phase I, Phase II, Phase III, Phase IV), By Therapeutic Area (Oncology, Cardiology, CNS Conditions, Pain Management, Endocrine, Others), By End User (Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies, Others), By Region, Competition, Forecast & Opportunities, 2020-2030F

Growing demand for decentralized trials and increasing adoption of real-world evidence in clinical research are the factors driving the United States Clinical Read More

United States CAR-T Cell Therapy Market, By Product (Abecma (idecabtagene vicleucel), Breyanzi (lisocabtagene maraleucel), Carvykti (ciltacabtagene autoleucel), Kymriah (tisagenlecleucel), Tecartus (brexucabtagene autoleucel), Yescarta (axicabtagene ciloleucel), Others), By Disease (Leukemia, Lymphoma, Multiple Myeloma, Others), By End User (Hospitals, Cancer Treatment Centers), By Region, Competition, Forecast & Opportunities, 2020-2030F

Increasing Incidence of Cancer and Aging Population are factors driving the United States CAR-T Cell Therapy market in the forecast period 2026-2030.Read More

Japan Inflammatory Bowel Disease (IBD) Drugs Market By Disease Type (Crohn’s Disease and Ulcerative Colitis), By Drug Class (TNF Inhibitors, JAK Inhibitors, Aminosalicylates, Corticosteroids, and Others), By Route of Administration (Oral and Parenteral), By End User (Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies), By Region, Competition, Forecast & Opportunities, 2020-2030F

Increasing incidence of IBD and advancements in diagnostic technologies are factors driving the Japan Inflammatory Bowel Disease (IBD) Drugs Market in the Read More

Japan Influenza Medications Market By Type (Antiviral Drugs, Antihistamines, Vaccines, Others), By Route of Administration (Oral, Inhaled), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Region, Competition, Forecast & Opportunities, 2020-2030F

Evolving influenza virus strains and rising incidence of influenza outbreaks are factors driving the Japan Influenza Medications Market in the forecast period Read More

Japan Kidney Cancer Drugs Market By Therapy (Immunotherapy, Chemotherapy, Targeted Therapy), By Drug Class (Monoclonal antibodies, Angiogenesis and mTOR Inhibitors), By Route of Administration (Oral, Intravenous and Subcutaneous), By Distribution Channel (Hospitals, Retail Pharmacies, Others), By Region, Competition, Forecast & Opportunities, 2020-2030F

Rising incidence of renal cell carcinoma (RCC) and advancements in targeted therapies & immunotherapies are factors driving the Japan Kidney Cancer Drugs Market Read More

Japan Lipid Lowering Drugs Market, By Drug (Statins & Combination, PCSK9 Inhibitors, Bile Acid Sequestrants, Fibrates, Cholesterol Absorption Inhibitors, Others), By Indication (Hypercholesterolemia, Coronary Artery Disease, High Triglycerides), By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies), By Region, Competition, Forecast & Opportunities, 2020-2030F

Advancements in pharmaceutical research and increasing prevalence of cardiovascular diseases are factors driving the Japan Lipid Lowering Drugs Market in the Read More

Japan Gastrointestinal Drugs Market By Type (Branded and Generics), By Drug Class (Aminosalicylates, Digestive enzymes, Proton Pump Inhibitors, Laxatives, Anti-Emetics, H2 Antagonists, Anti-Diarrheal, Biologics/Biosimilar, and Others), By Application (Crohn’s Disease, Ulcerative Colitis, GERD, IBS), By Route Of Administration (Oral, Injectable, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Region, Competition, Forecast & Opportunities, 2020-2030F

Increasing availability and acceptance of over-the-counter (OTC) gastrointestinal medications are factors driving the Japan Gastrointestinal Drugs Market in the Read More

Japan Glaucoma Drugs Market By Indication (Open Angle Glaucoma, Angle Closure Glaucoma, Others), By Drug Class (Prostaglandin Analogs, Beta Blockers, Alpha Agonist, Carbonic Anhydrase Inhibitors, Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), By Region, Competition, Forecast & Opportunities, 2020-2030F

Increased prevalence of glaucoma, and advancements in drug therapies are factors driving the Japan Glaucoma Drugs Market in the forecast period 2026-2030.Read More

Japan Gynecology Drugs Market By Therapeutics (Hormonal Therapy and Non-Hormonal Therapy), By Indication (Gynecology Cancers, Menopausal Disorder, Polycystic Ovary Syndrome, Contraception, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Region, Competition, Forecast & Opportunities, 2020-2030F

Expansion of distribution channels and increasing prevalence of gynecological disorders are factors driving the Japan Gynecology Drugs Market in the forecast Read More

Japan Human Insulin Market By Product Type (Rapid-Acting Insulin, Long-Acting Insulin, Combination Insulin, Biosimilars), By Application (Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus), By Type (Human Insulin, Insulin Analog), By Distribution Channel (Hospitals, Retail Pharmacies, and Others), By Region, Competition, Forecast & Opportunities, 2020-2030F

Rising prevalence of diabetes and development of innovative insulin formulations are factors driving the Japan Human Insulin Market in the forecast period Read More

Japan Immunosuppressant Drugs Market By Drug Class (Calcineurin Inhibitors, Antiproliferative Agents, MTOR Inhibitor, Steroids, and Others), By Application (Autoimmune Diseases, Organ Transplant, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Region, Competition, Forecast & Opportunities, 2020-2030F

Innovations in immunosuppressant drug formulations and expanding need for organ transplantation are factors driving the Japan Immunosuppressant Drugs Market in Read More

Indonesia Regenerative Medicine Market By Type (Cell Therapy, Gene Modification, Tissue Engineering, Others), By Application (Bone Graft Substitutes, Osteoarticular Diseases, Dermatology, Cardiovascular Diseases, Others), By End User (Academic Institutions and Hospitals & Clinics), By Region, Competition, Forecast and Opportunities, 2020-2030F

Rising Prevalence of Chronic Diseases and Aging Population are factors driving the Indonesia Regenerative Medicine Market in the forecast period, 2026-2030.Read More

India Rifampicin Market, By Source (In-house, Contract Manufacturing Organizations), By Form (Tablet, Capsule, Injection), By Route of Administration (Oral, Intravenous), By Distribution Channel (Online, Offline), By Application (Tuberculosis, Leprosy, Legionnaire's Disease, Others), By End User (Adult, Paediatric), By Region, Competition, Forecast & Opportunities, 2020-2030F

High Tuberculosis (TB) Burden and Strong Demand for Fixed-Dose Combination (FDC) Therapies are factors driving the India Rifampicin market in the forecast period Read More

Prev    Page 22 of 30 Next